title: Severe winter asthma exacerbations can be prevented by omalizumab, but there is no carryover effect.
authors.affiliation: Children's Health Queensland and the Child Health Research Centre, University of Queensland, Brisbane, Australia. Electronic address: p.sly@uq.edu.au.
authors.forename: Peter D
authors.initials: PD
authors.lastname: Sly
authors.affiliation: Children's Health Queensland and the Child Health Research Centre, University of Queensland, Brisbane, Australia.
authors.forename: Julie
authors.initials: J
authors.lastname: Varghese
authors.affiliation: Children's Health Queensland and the Child Health Research Centre, University of Queensland, Brisbane, Australia.
authors.forename: Farhana
authors.initials: F
authors.lastname: Noor
authors.affiliation: Murdoch Children's Research Institute, University of Melbourne, and Royal Children's Hospital, Melbourne, Australia.
authors.forename: Mimi L K
authors.initials: ML
authors.lastname: Tang
authors.affiliation: Telethon Kids Institute, Perth, Australia; School of Paediatric and Child Health, University of Western Australia, Perth, Australia.
authors.forename: Ingrid
authors.initials: I
authors.lastname: Laing
authors.affiliation: School of Paediatric and Child Health, University of Western Australia, Perth, Australia; Respiratory and Sleep Department, Princess Margaret Hospital, Perth, Australia.
authors.forename: Steve
authors.initials: S
authors.lastname: Oo
authors.affiliation: Telethon Kids Institute, Perth, Australia; School of Paediatric and Child Health, University of Western Australia, Perth, Australia.
authors.forename: Franciska
authors.initials: F
authors.lastname: Prastanti
authors.affiliation: School of Paediatric and Child Health, University of Western Australia, Perth, Australia.
authors.forename: Peter N
authors.initials: PN
authors.lastname: LeSouef
authors.affiliation: Telethon Kids Institute, Perth, Australia.
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Holt
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000453:epidemiology / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D000069444:Omalizumab / Q000008:administration & dosage* / Q000009:adverse effects; D012621:Seasons; D012720:Severity of Illness Index
chemical_list: D000069444:Omalizumab